Short communication: Effect of supplementation with Lactobacillus casei Shirota on insulin sensitivity, β-cell function, and markers of endothelial function and inflammation in subjects with metabolic syndrome-A pilot study

Journal of Dairy Science

Volumn 96, Issue 1, 2013, Pages 89-95

  Tripolt, N J ^a   Leber, B ^b   Blattl, D ^b   Eder, M ^a   Wonisch, W ^c   Scharnagl, H ^c   Stojakovic, T ^c   Obermayer Pietsch, B ^a   Wascher, T C ^d   Pieber, T R ^a   Stadlbauer, V ^c   Sourij, H ^a  

^a Department of Pediatrics   (Austria)

^b Department of Surgery   (Austria)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d HANUSCH HOSPITAL   (Austria)

Author keywords

Endothelial function; Insulin sensitivity; Lactobacillus casei Shirota; Metabolic syndrome

Indexed keywords

PROBIOTIC AGENT;

ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; GLUCOSE TOLERANCE TEST; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LACTOBACILLUS CASEI; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; PANCREAS ISLET BETA CELL; PHYSIOLOGY; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; VASCULAR ENDOTHELIUM;

DIETARY SUPPLEMENTS; ENDOTHELIUM, VASCULAR; GLUCOSE TOLERANCE TEST; HUMANS; INFLAMMATION; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LACTOBACILLUS CASEI; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PILOT PROJECTS; PROBIOTICS;

ANIMALIA; BACTERIA (MICROORGANISMS); LACTOBACILLUS CASEI;

EID: 84871606895     PISSN: 00220302     EISSN: 15253198     Source Type: Journal    
DOI: 10.3168/jds.2012-5863     Document Type: Article

References (27)

1. Alberti K.G., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., Fruchart J.C., James W.P., Loria C.M., Smith S.C. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645.
2. Andreasen A.S., Larsen N., Pedersen-Skovsgaard T., Berg R.M., Moller K., Svendsen K.D., Jakobsen M., Pedersen B.K. Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects. Br. J. Nutr. 2010, 104:1831-1838.
3. Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., Neyrinck A.M., Fava F., Tuohy K.M., Chabo C., Waget A., Delmee E., Cousin B., Sulpice T., Chamontin B., Ferrieres J., Tanti J.F., Gibson G.R., Casteilla L., Delzenne N.M., Alessi M.C., Burcelin R. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56:1761-1772. a.
4. Cani P.D., Bibiloni R., Knauf C., Waget A., Neyrinck A.M., Delzenne N.M., Burcelin R. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008, 57:1470-1481.
5. Cani P.D., Neyrinck A.M., Fava F., Knauf C., Burcelin R.G., Tuohy K.M., Gibson G.R., Delzenne N.M. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007, 50:2374-2383. b.
6. Cefalu W.T. Animal models of type 2 diabetes: Clinical presentation and pathophysiological relevance to the human condition. ILAR J. 2006, 47:186-198.
7. Creely S.J., McTernan P.G., Kusminski C.M., Fisher M., Da Silva N.F., Khanolkar M., Evans M., Harte A.L., Kumar S. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 2007, 292:E740-E747.
8. Gruber S., Pinker K., Riederer F., Chmelik M., Stadlbauer A., Bittsansky M., Mlynarik V., Frey R., Serles W., Bodamer O., Moser E. Metabolic changes in the normal ageing brain: Consistent findings from short and long echo time proton spectroscopy. Eur. J. Radiol. 2008, 68:320-327.
9. Katz A., Nambi S.S., Mather K., Baron A.D., Follmann D.A., Sullivan G., Quon M.J. Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans. J. Clin. Endocrinol. Metab. 2000, 85:2402-2410.
10. Keaney J.F., Larson M.G., Vasan R.S., Wilson P.W., Lipinska I., Corey D., Massaro J.M., Sutherland P., Vita J.A., Benjamin E.J. Obesity and systemic oxidative stress: Clinical correlates of oxidative stress in the Framingham Study. Arterioscler. Thromb. Vasc. Biol. 2003, 23:434-439.
11. Larsen N., Vogensen F.K., van den Berg F.W., Nielsen D.S., Andreasen A.S., Pedersen B.K., Al-Soud W.A., Sorensen S.J., Hansen L.H., Jakobsen M. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 2010, 5:e9085.
12. Ley R.E., Backhed F., Turnbaugh P., Lozupone C.A., Knight R.D., Gordon J.I. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. USA 2005, 102:11070-11075.
13. Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. Microbial ecology: Human gut microbes associated with obesity. Nature 2006, 444:1022-1023.
14. Li Z., Yang S., Lin H., Huang J., Watkins P.A., Moser A.B., Desimone C., Song X.Y., Diehl A.M. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 2003, 37:343-350.
15. Matsuda M., DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp. Diabetes Care 1999, 22:1462-1470.
16. Matsumoto K., Takada T., Shimizu K., Moriyama K., Kawakami K., Hirano K., Kajimoto O., Nomoto K. Effects of a probiotic fermented milk beverage containing Lactobacillus casei strain Shirota on defecation frequency, intestinal microbiota, and the intestinal environment of healthy individuals with soft stools. J. Biosci. Bioeng. 2010, 110:547-552.
17. Matsuzaki T., Yamazaki R., Hashimoto S., Yokokura T. Antidiabetic effects of an oral administration of Lactobacillus casei in a non-insulin-dependent diabetes mellitus (NIDDM) model using KK-Ay mice. Endocr. J. 1997, 44:357-365.
18. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
19. Naito E., Yoshida Y., Makino K., Kounoshi Y., Kunihiro S., Takahashi R., Matsuzaki T., Miyazaki K., Ishikawa F. Beneficial effect of oral administration of Lactobacillus casei strain Shirota on insulin resistance in diet-induced obesity mice. J. Appl. Microbiol. 2011, 110:650-657.
20. Shirota M., Aso K., Iwabuchi A. Studies on intestinal microflora. 1. Its constitution in healthy infants and the effect of oral administration of L. acidophilus strain Shirota. Nippon Saikingaku Zasshi 1966, 21:274-283.
21. Stumvoll M., Van Haeften T., Fritsche A., Gerich J. Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times. Diabetes Care 2001, 24:796-797.
22. Tatzber F., Esterbauer H. Autoantibodies to oxidized low-density lipoprotein. Free Radicals IX 1995, 245-262. Richelieu Press, London, UK. G. Bellomo, G. Finardi, E. Maggi, C. Rice-Evans (Eds.).
23. Thomas G.N., Schooling C.M., McGhee S.M., Ho S.Y., Cheung B.M., Wat N.M., Janus E.D., Lam K.S., Lam T.H. Metabolic syndrome increases all-cause and vascular mortality: The Hong Kong Cardiovascular Risk Factor Study. Clin. Endocrinol. (Oxf.) 2007, 66:666-671.
24. van Hecke M.V., Dekker J.M., Nijpels G., Moll A.C., Heine R.J., Bouter L.M., Polak B.C.P., Stehouwer C.D.A. Inflammation and endothelial dysfunction are associated with retinopathy: The Hoorn Study. Diabetologia 2005, 48:1300-1306.
25. Whitlock G., Lewington S., Sherliker P., Clarke R., Emberson J., Halsey J., Qizilbash N., Collins R., Peto R. Body-mass index and cause-specific mortality in 900 000 adults: Collaborative analyses of 57 prospective studies. Lancet 2009, 373:1083-1096.
26. Wos-Oxley M., Bleich A., Oxley A.P., Kahl S., Janus L., Smoczek A., Nahrstedt H., Pils M., Taudien S., Platzer M., Hedrich H.J., Medina E., Pieper D. Comparative evaluation of establishing a human gut microbial community within rodent models. Gut Microbes 2012, 3:234-249.
27. Zarfeshani A., Khaza'ai H., Mohd Ali R., Hambali Z., Wahle K., Mutalib M. Effect of Lactobacillus casei Shirota on the production of pro-inflammatory markers in streptozotocin-induced diabetic rats. Probiotics Antimicrob. Proteins 2011, 3:168-174.